AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27387494 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 46
Study 27387494 — intervention group
Group type: COMPARATOR
Intervention: Postural correction exercises (PCE)
Number of subjects: 46
Study 25928870 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow cortical potential (SCP) feedback
Number of subjects: 0
Study 25928870 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS) feedback
Number of subjects: 0
Study 25928870 — intervention group
Group type: COMPARATOR
Intervention: Nonspecific biofeedback treatment
Number of subjects: 0
Study 25928870 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 24298764 — intervention group
Group type: EXPERIMENTAL
Intervention: Bloodletting therapy at Jing‐well points
Number of subjects: 90
Study 24298764 — intervention group
Group type: COMPARATOR
Intervention: Semen coicis preparation
Number of subjects: 90
Study 24298764 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive therapy (bloodletting therapy and semen coicis preparation)
Number of subjects: 90
Study 22184553 — intervention group
Group type: EXPERIMENTAL
Intervention: Deteriorating patient-based simulation (DPS)
Number of subjects: 72
Study 22184553 — intervention group
Group type: COMPARATOR
Intervention: Standardized patients (SPs)
Number of subjects: 72
Study 19253793 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunonutrient containing enteral formula (group A)
Number of subjects: 40
Study 19253793 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral formula (group B)
Number of subjects: 40
Study 16685008 — intervention group
Group type: EXPERIMENTAL
Intervention: Active heat exchanger mask
Number of subjects: 15
Study 16685008 — intervention group
Group type: COMPARATOR
Intervention: Placebo mask
Number of subjects: 15
Study 16685008 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat exchanger mask
Number of subjects: 15
Study 16685008 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol pretreatment
Number of subjects: 15
Study 16685008 — intervention group
Group type: EXPERIMENTAL
Intervention: Unprotected exercise
Number of subjects: 15
Study 14993633 — intervention group
Group type: EXPERIMENTAL
Intervention: ROM (rifampin 600 mg, ofloxacin 400 mg, minocycline 100 mg)
Number of subjects: 21
Study 14993633 — intervention group
Group type: COMPARATOR
Intervention: MDT (rifampin 600 mg, clofazimine 300 mg, dapsone 100 mg, clofazimine 50 mg)
Number of subjects: 21
Study 11485587 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-tubercular treatment
Number of subjects: 1343
Study 11485587 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative management
Number of subjects: 1343
Study 9230332 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha(2a)-interferon (3 mU/m2)
Number of subjects: 10
Study 7954998 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard block level (T10 or higher)
Number of subjects: 23
Study 7954998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate block level (L1 or T12)
Number of subjects: 23
Study 7954998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low block level (L3 or lower)
Number of subjects: 23
Study 7954998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low block level (inadequate block)
Number of subjects: 23
Study 7954998 — intervention group
Group type: EXPERIMENTAL
Intervention: Low block level (adequate block)
Number of subjects: 23
Study 3825981 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women (pooled)
Number of subjects: 24
Study 3825981 — intervention group
Group type: COMPARATOR
Intervention: Lean women
Number of subjects: 24
Study 3825981 — intervention group
Group type: EXPERIMENTAL
Intervention: Obese women (AOO and COO)
Number of subjects: 24
Study 3825981 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat-free mass (FFM)
Number of subjects: 24
Study 30484757 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal protein intake in early pregnancy (g/d per kg)
Number of subjects: 570
Study 30484757 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal protein intake from 6 months to 5 years (g/d per kg)
Number of subjects: 570
Study 28806537 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration (2000 ml of water)
Number of subjects: 164
Study 28806537 — intervention group
Group type: COMPARATOR
Intervention: Control (no more than 100 ml of water)
Number of subjects: 164
Study 26618557 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan-coated garment
Number of subjects: 78
Study 26618557 — intervention group
Group type: COMPARATOR
Intervention: Uncoated cotton garment (Control)
Number of subjects: 78
Study 24042189 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold snare polypectomy (CSP)
Number of subjects: 54
Study 24042189 — intervention group
Group type: COMPARATOR
Intervention: Cold forceps polypectomy (CFP)
Number of subjects: 54
Study 21441125 — intervention group
Group type: EXPERIMENTAL
Intervention: Qa <650 ml/min in distal fistulae
Number of subjects: 119
Study 21441125 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive PE and Qa <900 ml/min in proximal fistulae
Number of subjects: 119
Study 21441125 — intervention group
Group type: EXPERIMENTAL
Intervention: PE and VAPR >0.5 in proximal fistulae
Number of subjects: 119
Study 21441125 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored screening approach
Number of subjects: 119
Study 21441125 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedside screening program with ≥85% accuracy
Number of subjects: 119
Study 18568520 — intervention group
Group type: EXPERIMENTAL
Intervention: N(2)O inhalation (10 breaths of 50% N(2)O/50% O(2))
Number of subjects: 90
Study 18568520 — intervention group
Group type: COMPARATOR
Intervention: Room air inhalation
Number of subjects: 90
Study 18568520 — intervention group
Group type: COMPARATOR
Intervention: Local anesthesia only
Number of subjects: 90
Study 17205818 — intervention group
Group type: EXPERIMENTAL
Intervention: Huashi Decoction (HD)
Number of subjects: 70
Study 17205818 — intervention group
Group type: COMPARATOR
Intervention: Nucleotide analogies (Control)
Number of subjects: 70
Study 12975669 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine/5‐fluorouracil (5FU)/leucovorin combination
Number of subjects: 34
Study 12975669 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine/cisplatin
Number of subjects: 34
Study 11094000 — intervention group
Group type: COMPARATOR
Intervention: 10 mg of isobaric bupivacaine (0.2%)
Number of subjects: 100
Study 11094000 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of isobaric ropivacaine (0.3%)
Number of subjects: 100
Study 8826511 — intervention group
Group type: EXPERIMENTAL
Intervention: Marital conflict/stress in chronic pain couples
Number of subjects: 61
Study 8826511 — intervention group
Group type: EXPERIMENTAL
Intervention: Punitive spouse behaviors
Number of subjects: 61
Study 1595337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine in combination with rectally administered naproxen 1000 mg/24 h
Number of subjects: 125
Study 1595337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine in combination with paracetamol 4000 mg/24 h
Number of subjects: 125
Study 1595337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study 1595337 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine as a sole agent
Number of subjects: 125
Study 6362760 — intervention group
Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 8
Study 6362760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31464192 — intervention group
Group type: EXPERIMENTAL
Intervention: Receipt of weekly recommendations
Number of subjects: 301
Study 31464192 — intervention group
Group type: EXPERIMENTAL
Intervention: Coaching
Number of subjects: 301
Study 31464192 — intervention group
Group type: EXPERIMENTAL
Intervention: Coached treatment
Number of subjects: 301
Study 31464192 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment arms
Number of subjects: 301
Study 31464192 — intervention group
Group type: EXPERIMENTAL
Intervention: Receiving recommendations
Number of subjects: 301
Study 29712507 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 124
Study 29712507 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 27379182 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent mentor intervention
Number of subjects: 60
Study 27379182 — intervention group
Group type: COMPARATOR
Intervention: Community health worker comparison
Number of subjects: 60
Study 23917458 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid administered in 2 doses (1 hour preoperatively and 6 hours postoperatively)
Number of subjects: 99
Study 23917458 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in the abstract)
Number of subjects: 99
Study 22464576 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment (aspirin + low molecular weight heparin)
Number of subjects: 110
Study 22464576 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of conventional treatment and clopidogrel
Number of subjects: 110
Study 22464576 — intervention group
Group type: COMPARATOR
Intervention: Healthy control group
Number of subjects: 110
Study 22464576 — intervention group
Group type: COMPARATOR
Intervention: Ischemic cardiomyopathy (ICM) group
Number of subjects: 110
Study 20044534 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target systolic BP 140 mmHg)
Number of subjects: 404
Study 20044534 — intervention group
Group type: COMPARATOR
Intervention: Standard guideline-based management of BP (target systolic BP 180 mmHg)
Number of subjects: 404
Study 18327838 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological agents for inducing hyperaemia during coronary physiology studies
Number of subjects: 0
Study 18327838 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary pressure wire studies
Number of subjects: 0
Study 15899049 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 15 mg
Number of subjects: 284
Study 15899049 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg
Number of subjects: 284
Study 15899049 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 284
Study 15899049 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (both doses)
Number of subjects: 284
Study 12356708 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational outreach visit
Number of subjects: 60
Study 12356708 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing professional education session
Number of subjects: 60
Study 12356708 — intervention group
Group type: COMPARATOR
Intervention: Postal dissemination of evidence-based guideline (control)
Number of subjects: 60
Study 11730758 — intervention group
Group type: COMPARATOR
Intervention: Intrauterine insemination (IUI)
Number of subjects: 132
Study 11730758 — intervention group
Group type: EXPERIMENTAL
Intervention: Fallopian sperm perfusion (FSP)
Number of subjects: 132
Study 9432085 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-2 sessions/wk plus a 240 kcal caloric restriction (1-2SW, N = 9)
Number of subjects: 26
Study 9432085 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-4 sessions/wk without caloric restriction (3-4SW, N = 9)
Number of subjects: 26
Study 9432085 — intervention group
Group type: COMPARATOR
Intervention: nonexercising control (C, N = 8)
Number of subjects: 26
Study 8392175 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention aimed at promoting low-fat, high-fiber eating
Number of subjects: 652
Study 3749616 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous administration of salbutamol and beclomethasone dipropionate from a combination inhaler
Number of subjects: 40
Study 3749616 — intervention group
Group type: COMPARATOR
Intervention: Sequential administration of salbutamol and beclomethasone dipropionate from separate inhalers with an interval of 10 min
Number of subjects: 40
Study 29268667 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus regular visits from a therapy dog
Number of subjects: 106
Study 29268667 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 106
Study 29268667 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 106
Study 27442086 — intervention group
Group type: EXPERIMENTAL
Intervention: TRP mouthwash
Number of subjects: 90
Study 27442086 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (CHX) mouthwash
Number of subjects: 90
Study 27442086 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthwash
Number of subjects: 90
Study 26206854 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal membrane oxygenation (ECMO) at listing
Number of subjects: 203
Study 26206854 — intervention group
Group type: COMPARATOR
Intervention: Ventricular assist device at listing
Number of subjects: 203
Study 26206854 — intervention group
Group type: COMPARATOR
Intervention: Not on ECMO or ventricular assist device at listing
Number of subjects: 203
Study 26206854 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplantation from ECMO
Number of subjects: 203
Study 26206854 — intervention group
Group type: COMPARATOR
Intervention: Transplantation from ventricular assist device
Number of subjects: 203
Study 26206854 — intervention group
Group type: COMPARATOR
Intervention: Transplantation not on ECMO/ventricular assist device
Number of subjects: 203
Study 26206854 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplantation from ECMO at age <1 year
Number of subjects: 203
Study 23989837 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin infiltration treatment for WSLs
Number of subjects: 0
Study 21965636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 450 mg/day
Number of subjects: 747
Study 21965636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 747
Study 21965636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 747
Study 21965636 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (all doses)
Number of subjects: 747
Study 21965636 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 747
Study 18507832 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and Omeprazole (OA)
Number of subjects: 770
Study 18507832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 770
Study 18507832 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy with OA and CLR (OAC)
Number of subjects: 770
Study 17073704 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostanoids (e.g., PGE(1)) used for treatment of peripheral arterial disease
Number of subjects: 0
Study 17073704 — intervention group
Group type: EXPERIMENTAL
Intervention: Irbesartan and simvastatin
Number of subjects: 0
Study 17073704 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-iso-PGF(2alpha) in serum
Number of subjects: 0
Study 14637328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dieters
Number of subjects: 40
Study 14637328 — intervention group
Group type: COMPARATOR
Intervention: Non-dieters
Number of subjects: 40
Study 11071802 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent implantation (AVE microstent, lengths 18-39 mm)
Number of subjects: 96
Study 11071802 — intervention group
Group type: COMPARATOR
Intervention: PTCA (no stent)
Number of subjects: 96
Study 8930429 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg
Number of subjects: 39
Study 8930429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 14621749 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasodilator drugs during organ procurement
Number of subjects: 31
Study 14621749 — intervention group
Group type: COMPARATOR
Intervention: Dopamine (greater than 4 microg/kg per min)
Number of subjects: 31
Study 30161045 — intervention group
Group type: EXPERIMENTAL
Intervention: Ptosis repair (levator resection)
Number of subjects: 78
Study 30161045 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower levator function (LF)
Number of subjects: 78
Study 26564102 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrolysin (30 mL/d) for 21 days
Number of subjects: 0
Study 26564102 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline) for 21 days
Number of subjects: 0
Study 26571321 — intervention group
Group type: EXPERIMENTAL
Intervention: 980-nm diode laser vaporization (PVP)
Number of subjects: 72
Study 26571321 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 72
Study 26571321 — intervention group
Group type: EXPERIMENTAL
Intervention: Both PVP and TURP
Number of subjects: 72
Study 23547851 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin and levamisole (Group 1)
Number of subjects: 169
Study 23547851 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin alone (Group 2)
Number of subjects: 169
Study 20508185 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality using Nintendo Wii gaming system (VRWii)
Number of subjects: 22
Study 20508185 — intervention group
Group type: COMPARATOR
Intervention: Recreational therapy (playing cards, bingo, or 'Jenga')
Number of subjects: 22
Study 17898015 — intervention group
Group type: EXPERIMENTAL
Intervention: Septoplasty (surgery group; 27 patients)
Number of subjects: 49
Study 17898015 — intervention group
Group type: COMPARATOR
Intervention: Sham surgery (placebo group; 22 patients)
Number of subjects: 49
Study 16873669 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP induction (R: 375 mg/m² intravenously, day 1)
Number of subjects: 465
Study 16873669 — intervention group
Group type: EXPERIMENTAL
Intervention: R maintenance (375 mg/m² intravenously once every 3 months for a maximum of 2 years)
Number of subjects: 465
Study 16873669 — intervention group
Group type: COMPARATOR
Intervention: Observation (control group)
Number of subjects: 465
Study 16873669 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP induction
Number of subjects: 465
Study 16873669 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP induction
Number of subjects: 465
Study 16873669 — intervention group
Group type: EXPERIMENTAL
Intervention: R maintenance
Number of subjects: 465
Study 14608138 — intervention group
Group type: EXPERIMENTAL
Intervention: In-hospital initiation of cardiovascular protective medications (including antiplatelet therapy, beta-blockers, ACE inhibitors, and lipid-lowering therapy)
Number of subjects: 0
Study 14608138 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (conventional care without in-hospital initiation)
Number of subjects: 0
Study 11067793 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 microgram dofetilide
Number of subjects: 325
Study 11067793 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 microgram dofetilide
Number of subjects: 325
Study 11067793 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 microgram dofetilide
Number of subjects: 325
Study 11067793 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study 11067793 — intervention group
Group type: EXPERIMENTAL
Intervention: Dofetilide (all dosages)
Number of subjects: 325
Study 8872627 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression Method
Number of subjects: 6
Study 8872627 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter Method
Number of subjects: 6
Study 1634926 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa (75 mg/m2) + GM-CSF (10 micrograms/kg)
Number of subjects: 13
Study 1634926 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa (75 mg/m2) + GM-CSF (5 micrograms/kg)
Number of subjects: 13
Study 1634926 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa (75 mg/m2) + GM-CSF (10 or 5 micrograms/kg)
Number of subjects: 13
Study 6202572 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 0
Study 6202572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31352424 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Palliative Care Education, Training and Technical Support (PRIM-ER)
Number of subjects: 300000
Study 29117063 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 111
Study 29117063 — intervention group
Group type: COMPARATOR
Intervention: Nondexmedetomidine
Number of subjects: 111
Study 26859707 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term training (LTT) for 5 days
Number of subjects: 34
Study 26859707 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term training (STT) for 30 minutes
Number of subjects: 34
Study 26859707 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 34
Study 25370364 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy for Obesity (CRT‐O)
Number of subjects: 90
Study 25370364 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 90
Study 23040775 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position in ARDSexp group (n=10)
Number of subjects: 41
Study 23040775 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone position in ARDSp group (n=11)
Number of subjects: 41
Study 23040775 — intervention group
Group type: COMPARATOR
Intervention: Supine position in ARDSp group (n=9)
Number of subjects: 41
Study 23040775 — intervention group
Group type: COMPARATOR
Intervention: Supine position in ARDSexp group (n=11)
Number of subjects: 41
Study 19833893 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary weight loss (WL)
Number of subjects: 59
Study 19833893 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary weight loss and moderate‐intensity aerobic exercise (WL+EX)
Number of subjects: 59
Study 19833893 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 59
Study 16231038 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat restriction
Number of subjects: 962
Study 16231038 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased exercise
Number of subjects: 962
Study 16231038 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate or substantial exercise increase with fat restriction
Number of subjects: 962
Study 16231038 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise increases at all levels of dietary fat change
Number of subjects: 962
Study 12740277 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS)
Number of subjects: 43